Natally Horvat1, David D B Bates2, Iva Petkovska3. 1. Department of Radiology, Hospital Sirio-Libanes, Sao Paulo, SP, Brazil. 2. Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY, 10065, USA. 3. Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY, 10065, USA. petkovsi@mskcc.org.
Abstract
INTRODUCTION: As computational capabilities have advanced, radiologists and their collaborators have looked for novel ways to analyze diagnostic images. This has resulted in the development of radiomics and radiogenomics as new fields in medical imaging. Radiomics and radiogenomics may change the practice of medicine, particularly for patients with colorectal cancer. Radiomics corresponds to the extraction and analysis of numerous quantitative imaging features from conventional imaging modalities in correlation with several endpoints, including the prediction of pathology, genomics, therapeutic response, and clinical outcome. In radiogenomics, qualitative and/or quantitative imaging features are extracted and correlated with genetic profiles of the imaged tissue. Thus far, several studies have evaluated the use of radiomics and radiogenomics in patients with colorectal cancer; however, there are challenges to be overcome before its routine implementation including challenges related to sample size, model design and interpretability, and the lack of robust multicenter validation set. MATERIAL AND METHODS: In this article, we will review the concepts of radiomics and radiogenomics and their potential applications in rectal cancer. CONCLUSION: Radiologists should be aware of the basic concepts, benefits, pitfalls, and limitations of new radiomic and radiogenomics techniques to achieve a balanced interpretation of the results.
INTRODUCTION: As computational capabilities have advanced, radiologists and their collaborators have looked for novel ways to analyze diagnostic images. This has resulted in the development of radiomics and radiogenomics as new fields in medical imaging. Radiomics and radiogenomics may change the practice of medicine, particularly for patients with colorectal cancer. Radiomics corresponds to the extraction and analysis of numerous quantitative imaging features from conventional imaging modalities in correlation with several endpoints, including the prediction of pathology, genomics, therapeutic response, and clinical outcome. In radiogenomics, qualitative and/or quantitative imaging features are extracted and correlated with genetic profiles of the imaged tissue. Thus far, several studies have evaluated the use of radiomics and radiogenomics in patients with colorectal cancer; however, there are challenges to be overcome before its routine implementation including challenges related to sample size, model design and interpretability, and the lack of robust multicenter validation set. MATERIAL AND METHODS: In this article, we will review the concepts of radiomics and radiogenomics and their potential applications in rectal cancer. CONCLUSION: Radiologists should be aware of the basic concepts, benefits, pitfalls, and limitations of new radiomic and radiogenomics techniques to achieve a balanced interpretation of the results.
Authors: Roberto Berenguer; María Del Rosario Pastor-Juan; Jesús Canales-Vázquez; Miguel Castro-García; María Victoria Villas; Francisco Mansilla Legorburo; Sebastià Sabater Journal: Radiology Date: 2018-04-24 Impact factor: 11.105
Authors: Davide Cusumano; Nicola Dinapoli; Luca Boldrini; Giuditta Chiloiro; Roberto Gatta; Carlotta Masciocchi; Jacopo Lenkowicz; Calogero Casà; Andrea Damiani; Luigi Azario; Johan Van Soest; Andre Dekker; Philippe Lambin; Marco De Spirito; Vincenzo Valentini Journal: Radiol Med Date: 2017-12-11 Impact factor: 3.469
Authors: O Jalil; A Afaq; B Ganeshan; U B Patel; D Boone; R Endozo; A Groves; B Sizer; T Arulampalam Journal: Colorectal Dis Date: 2017-04 Impact factor: 3.788
Authors: Katja Pinker; Fuki Shitano; Evis Sala; Richard K Do; Robert J Young; Andreas G Wibmer; Hedvig Hricak; Elizabeth J Sutton; Elizabeth A Morris Journal: J Magn Reson Imaging Date: 2017-11-02 Impact factor: 4.813
Authors: Kenneth A Miles; Balaji Ganeshan; Manuel Rodriguez-Justo; Vicky J Goh; Zia Ziauddin; Alec Engledow; Marie Meagher; Raymondo Endozo; Stuart A Taylor; Stephen Halligan; Peter J Ell; Ashley M Groves Journal: J Nucl Med Date: 2014-02-10 Impact factor: 10.057
Authors: Kathryn E Keenan; Jana G Delfino; Kalina V Jordanova; Megan E Poorman; Prathyush Chirra; Akshay S Chaudhari; Bettina Baessler; Jessica Winfield; Satish E Viswanath; Nandita M deSouza Journal: Med Phys Date: 2021-09-29 Impact factor: 4.506
Authors: Peter Mbanu; Mark P Saunders; Hitesh Mistry; Joe Mercer; Lee Malcomson; Saif Yousif; Gareth Price; Rohit Kochhar; Andrew G Renehan; Marcel van Herk; Eliana Vasquez Osorio Journal: Phys Imaging Radiat Oncol Date: 2022-06-28
Authors: Jacob T Antunes; Asya Ofshteyn; Kaustav Bera; Erik Y Wang; Justin T Brady; Joseph E Willis; Kenneth A Friedman; Eric L Marderstein; Matthew F Kalady; Sharon L Stein; Andrei S Purysko; Rajmohan Paspulati; Jayakrishna Gollamudi; Anant Madabhushi; Satish E Viswanath Journal: J Magn Reson Imaging Date: 2020-03-26 Impact factor: 4.813
Authors: Charlems Alvarez-Jimenez; Jacob T Antunes; Nitya Talasila; Kaustav Bera; Justin T Brady; Jayakrishna Gollamudi; Eric Marderstein; Matthew F Kalady; Andrei Purysko; Joseph E Willis; Sharon Stein; Kenneth Friedman; Rajmohan Paspulati; Conor P Delaney; Eduardo Romero; Anant Madabhushi; Satish E Viswanath Journal: Cancers (Basel) Date: 2020-07-24 Impact factor: 6.639